SecBot SecBot
8-K ·Filed Nov 12, 2026

EYE

National Vision Holdings, Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed4d 20h ago SEC0001710155-26-000006
8-K Item 2.02: Earnings release
Actionable Insight • Neutral

The lowered full-year guidance on revenue and comps signals near-term consumer headwinds, partially offset by strong margin expansion and a new $100M buyback. Monitor Q4 same-store sales trends and any further guidance revisions.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$18.57
T+0 close · Nov 12, 2026 · via day close
Latest settled
−1.48%
T+1 · $18.30
Vs SPY
−1.12%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $18.57entry
  2. T+1 · 4d ago −1.48%α −1.12% · $18.30
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

National Vision reported Q3 2026 revenue of $510.5M (+4.8% YoY) and adjusted diluted EPS of $0.30, more than doubling from $0.13 a year ago. Adjusted operating margin expanded 320 bps to 7.3%, but the company lowered its full-year guidance for revenue and adjusted comparable store sales growth, reflecting a cautious consumer outlook. A new $100M share repurchase authorization was also announced.

Key Financial Metrics

EPS (Adj.)
$0.30
est $0.17 · +76.5% · GAAP: $0.24
Revenue
$510.5M
est $512.6M · -0.4% · +4.8% YoY
Rating
beat
Guidance
$2.019B-$2.038B
lowered

Key Facts

  • Q3 2026 net revenue of $510.5M, up 4.8% YoY from $487.3M
  • Adjusted diluted EPS of $0.30, up from $0.13 YoY (more than doubled)
  • GAAP diluted EPS of $0.24, up from $0.04 YoY
  • Adjusted operating income of $37.1M, up 87.4% from $19.8M YoY
  • Adjusted operating margin expanded 320 bps to 7.3% from 4.1%
  • Comparable store sales growth of 3.6%; adjusted comparable store sales growth of 2.8%
  • Full-year 2026 guidance lowered: net revenue now $2.019B-$2.038B (from $2.037B-$2.076B); adjusted comparable store sales growth now 2.0%-3.0% (from 3.0%-5.0%)
  • New $100M share repurchase authorization approved, replacing prior $10M remaining authorization
  • Company repurchased 1.1M shares for $20.0M during Q3
  • Cash balance of $60.0M; no borrowings on $300M revolver; total debt of $233.6M

Financial Impact

Revenue of $510.5M slightly below consensus of $512.6M; adjusted EPS of $0.30 well above consensus of $0.17. Guidance lowered for revenue and comps.

revenueepsoperating marginguidance

Segment Breakdown

SegmentGrowth
Americas Best+3.4%
Eyeglass World-2.5%
Military+1.9%
Fred Meyer+3.2%

Risk Factors

  • Lowered full-year revenue and comp guidance reflects cautious consumer environment
  • Self-pay customer traffic remains under pressure, partially offset by managed care strength
  • One-time IEEPA tariff refund of $4.7M benefited Q3 cost of goods; non-recurring

Market Snapshot

Exchange
Nasdaq
Sector
Ophthalmic Goods
Analyst Consensus
73% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001710155-26-000006
Document: eye-20261112.htm0001710155-26-000006
Document: 0001710155-26-000006-index-headers.html0001710155-26-000006
Document: 0001710155-26-000006-index.html0001710155-26-000006
Document: 0001710155-26-000006.txt0001710155-26-000006
8-K Data (Synthetic)0001710155-26-000006

US Market Status

Market Closed · Opens in 7h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026